These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17340060)

  • 21. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
    Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease.
    Papageorgiou N; Androulakis E; Papaioannou S; Antoniades C; Tousoulis D
    Amino Acids; 2015 Sep; 47(9):1741-50. PubMed ID: 26123985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric dimethylarginine in adults with cystathionine β-synthase deficiency.
    Rocha MS; Teerlink T; Janssen MC; Kluijtmans LA; Smulders Y; Jakobs C; Tavares de Almeida I; Rivera I; Castro R; Blom HJ
    Atherosclerosis; 2012 Jun; 222(2):509-11. PubMed ID: 22484094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of L-arginine/L-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients.
    Haghikia A; Yanchev GR; Kayacelebi AA; Hanff E; Bledau N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Bauersachs J; Bavendiek U; Tsikas D
    Amino Acids; 2017 Jun; 49(6):1111-1121. PubMed ID: 28285332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
    Ueda S; Yamagishi SI; Matsumoto Y; Fukami K; Okuda S
    Clin Exp Nephrol; 2007 Jun; 11(2):115-121. PubMed ID: 17593510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.
    Lentz SR; Rodionov RN; Dayal S
    Atheroscler Suppl; 2003 Dec; 4(4):61-5. PubMed ID: 14664904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitorization of asymmetric dimethylarginine (ADMA) levels in an experimental ischemia-reperfusion flap model: a preliminary report.
    Karaaslan O; Sonmez E; Kankaya Y; Silistreli OK; Can MM; Bedir YK; Caliskan G
    J Reconstr Microsurg; 2013 Jul; 29(6):417-20. PubMed ID: 23585188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine and asymmetric dimethylarginine in relation to B vitamins in elderly people.
    Fabian E; Kickinger A; Wagner KH; Elmadfa I
    Wien Klin Wochenschr; 2011 Aug; 123(15-16):496-501. PubMed ID: 21833599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asymmetric dimethylarginine, NO and collateral growth.
    Kocaman SA
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):417-20. PubMed ID: 19819795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
    Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
    Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats.
    De Gennaro Colonna V; Bonomo S; Ferrario P; Bianchi M; Berti M; Guazzi M; Manfredi B; Muller EE; Berti F; Rossoni G
    Eur J Pharmacol; 2007 Feb; 557(2-3):178-85. PubMed ID: 17258196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Asymmetric dimethylarginine--a novel cardiovascular risk factor].
    Siroká R; Cibulka R; Rajdl D; Racek J
    Vnitr Lek; 2006 Mar; 52(3):249-55. PubMed ID: 16722156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension.
    Perticone F; Sciacqua A; Maio R; Perticone M; Galiano Leone G; Bruni R; Di Cello S; Pascale A; Talarico G; Greco L; Andreozzi F; Sesti G
    Int J Cardiol; 2010 Jul; 142(3):236-41. PubMed ID: 19168237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
    Böger RH; Bode-Böger SM
    Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes.
    Das UN; Repossi G; Dain A; Eynard AR
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):13-20. PubMed ID: 21196155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does ADMA cause endothelial dysfunction?
    Cooke JP
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2032-7. PubMed ID: 10978245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal asymmetric dimethylarginine/nitric oxide balance in patients with documented coronary artery disease: relation to renal function and homocysteine.
    Ilhan N; Seckin D; Ilhan N; Ozbay Y
    J Thromb Thrombolysis; 2007 Jun; 23(3):205-11. PubMed ID: 17160550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus.
    Gajecki D; Gawryś J; Wiśniewski J; Fortuna P; Szahidewicz-Krupska E; Doroszko A
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.